• Home
  • News & Events
    • News Releases
    • Events & Presentations
    • Publications
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Governance Documents
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Annual Report and Proxy
    • Special Meeting Proxy
  • Stock Information
  • Resources
    • Email Alerts
    • Contact

Blue Water Vaccines Announces Closing of Initial Public Offering

Feb 23, 2022 | Press Releases

CINCINNATI, Feb. 23, 2022 — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing vaccines, today announced the closing of its initial public offering of 2,222,222...

Blue Water Vaccines Announces Closing of Initial Public Offering

Feb 23, 2022 | Press Releases

CINCINNATI, Feb. 23, 2022 — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing vaccines, today announced the closing of its initial public offering of 2,222,222...

Blue Water Vaccines Announces Pricing of approximate $20M Initial Public Offering

Feb 17, 2022 | Press Releases

CINCINNATI, Feb. 17, 2022 — Blue Water Vaccines, Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing vaccines, today announced the pricing of its initial public offering of 2,222,222...

Blue Water Vaccines Announces Pricing of approximate $20M Initial Public Offering

Feb 17, 2022 | Press Releases

CINCINNATI, Feb. 17, 2022 — Blue Water Vaccines, Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing vaccines, today announced the pricing of its initial public offering of 2,222,222...
Next Entries »

Recent Posts

  • Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement
  • Onconetix Announces Reverse Stock Split
  • Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
  • CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
  • Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

Recent Comments

No comments to show.

Stay up to date

Keep informed on investor news & updates

© 2026 Onconetix